These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24312026)

  • 1. Decanalization mediating gene-environment interactions in schizophrenia and other psychiatric disorders with neurodevelopmental etiology.
    Burrows EL; Hannan AJ
    Front Behav Neurosci; 2013; 7():157. PubMed ID: 24312026
    [No Abstract]   [Full Text] [Related]  

  • 2. Decanalization, brain development and risk of schizophrenia.
    McGrath JJ; Hannan AJ; Gibson G
    Transl Psychiatry; 2011 Jun; 1(6):e14. PubMed ID: 22832430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic imprinting and conflict-induced decanalization.
    Wilkins JF
    Evolution; 2011 Feb; 65(2):537-53. PubMed ID: 21029079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive endophenotypes, gene-environment interactions and experience-dependent plasticity in animal models of schizophrenia.
    Burrows EL; Hannan AJ
    Biol Psychol; 2016 Apr; 116():82-9. PubMed ID: 26687973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous Retroviruses Activity as a Molecular Signature of Neurodevelopmental Disorders.
    Balestrieri E; Matteucci C; Cipriani C; Grelli S; Ricceri L; Calamandrei G; Vallebona PS
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using mouse models of autism spectrum disorders to study the neurotoxicology of gene-environment interactions.
    Schwartzer JJ; Koenig CM; Berman RF
    Neurotoxicol Teratol; 2013; 36():17-35. PubMed ID: 23010509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Psychiatric and Neurodevelopmental Disorders Among Siblings of Probands With Autism Spectrum Disorders.
    Jokiranta-Olkoniemi E; Cheslack-Postava K; Sucksdorff D; Suominen A; Gyllenberg D; Chudal R; Leivonen S; Gissler M; Brown AS; Sourander A
    JAMA Psychiatry; 2016 Jun; 73(6):622-9. PubMed ID: 27145529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal Immune Activation by Poly I:C as a preclinical Model for Neurodevelopmental Disorders: A focus on Autism and Schizophrenia.
    Haddad FL; Patel SV; Schmid S
    Neurosci Biobehav Rev; 2020 Jun; 113():546-567. PubMed ID: 32320814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental Plasticity in Pre- and Postnatal Environmental Interactions: Implications for Psychiatric Disorders from an Evolutionary Perspective.
    Lee YA; Yamaguchi Y; Goto Y
    Neural Plast; 2015; 2015():291476. PubMed ID: 26060583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology-driven neurodevelopmental animal models of schizophrenia.
    Meyer U; Feldon J
    Prog Neurobiol; 2010 Mar; 90(3):285-326. PubMed ID: 19857543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical lateralization in neurodevelopmental and psychiatric disorders: What is the role of stress?
    Berretz G; Wolf OT; Güntürkün O; Ocklenburg S
    Cortex; 2020 Apr; 125():215-232. PubMed ID: 32035318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-environment interactions in mental disorders.
    Tsuang MT; Bar JL; Stone WS; Faraone SV
    World Psychiatry; 2004 Jun; 3(2):73-83. PubMed ID: 16633461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal Immune Activation and the Development of Dopaminergic Neurotransmission of the Offspring: Relevance for Schizophrenia and Other Psychoses.
    Aguilar-Valles A; Rodrigue B; Matta-Camacho E
    Front Psychiatry; 2020; 11():852. PubMed ID: 33061910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling neurodevelopmental and psychiatric diseases with human iPSCs.
    Wen Z
    J Neurosci Res; 2017 May; 95(5):1097-1109. PubMed ID: 28186671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-environment interactions informing therapeutic approaches to cognitive and affective disorders.
    Rogers J; Renoir T; Hannan AJ
    Neuropharmacology; 2019 Feb; 145(Pt A):37-48. PubMed ID: 29277490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Modifications in Schizophrenia and Related Disorders: Molecular Scars of Environmental Exposures and Source of Phenotypic Variability.
    Richetto J; Meyer U
    Biol Psychiatry; 2021 Feb; 89(3):215-226. PubMed ID: 32381277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal Antibody and ASD: Clinical Data and Animal Models.
    Gata-Garcia A; Diamond B
    Front Immunol; 2019; 10():1129. PubMed ID: 31191521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious and immune factors in the pathogenesis of neurodevelopmental disorders: epidemiology, hypotheses, and animal models.
    Hornig M; Lipkin WI
    Ment Retard Dev Disabil Res Rev; 2001; 7(3):200-10. PubMed ID: 11553936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology in psychiatry: embracing the reality of poly-gene-environmental causation of mental illness.
    Uher R; Zwicker A
    World Psychiatry; 2017 Jun; 16(2):121-129. PubMed ID: 28498595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental enrichment and brain repair: harnessing the therapeutic effects of cognitive stimulation and physical activity to enhance experience-dependent plasticity.
    Hannan AJ
    Neuropathol Appl Neurobiol; 2014 Feb; 40(1):13-25. PubMed ID: 24354721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.